These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27716850)

  • 1. Efficient Killing of High Risk Neuroblastoma Using Natural Killer Cells Activated by Plasmacytoid Dendritic Cells.
    Cordeau M; Belounis A; Lelaidier M; Cordeiro P; Sartelet H; Herblot S; Duval M
    PLoS One; 2016; 11(10):e0164401. PubMed ID: 27716850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.
    Lelaidier M; Dìaz-Rodriguez Y; Cordeau M; Cordeiro P; Haddad E; Herblot S; Duval M
    Oncotarget; 2015 Oct; 6(30):29440-55. PubMed ID: 26320191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients' NK cell stimulation with activated plasmacytoid dendritic cells increases dinutuximab-induced neuroblastoma killing.
    Belounis A; Ayoub M; Cordeiro P; Lemieux W; Teira P; Haddad E; Herblot S; Duval M
    Cancer Immunol Immunother; 2020 Sep; 69(9):1767-1779. PubMed ID: 32342128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGB1 Is Involved in IFN-α Production and TRAIL Expression by HIV-1-Exposed Plasmacytoid Dendritic Cells: Impact of the Crosstalk with NK Cells.
    Saïdi H; Bras M; Formaglio P; Melki MT; Charbit B; Herbeuval JP; Gougeon ML
    PLoS Pathog; 2016 Feb; 12(2):e1005407. PubMed ID: 26871575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of interferon-gamma from natural killer cells by immunostimulatory CpG DNA is mediated through plasmacytoid-dendritic-cell-produced interferon-alpha and tumour necrosis factor-alpha.
    Marshall JD; Heeke DS; Abbate C; Yee P; Van Nest G
    Immunology; 2006 Jan; 117(1):38-46. PubMed ID: 16423039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCMV infection of PDCs deviates the NK cell response into cytokine-producing cells unable to perform cytotoxicity.
    Cederarv M; Söderberg-Nauclér C; Odeberg J
    Immunobiology; 2009; 214(5):331-41. PubMed ID: 19152985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in vitro: mechanisms of imiquimod- and IFN-α-mediated antitumor reactivity.
    Kalb ML; Glaser A; Stary G; Koszik F; Stingl G
    J Immunol; 2012 Feb; 188(4):1583-91. PubMed ID: 22231699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cells display impaired responses to toll like receptor 9 that support viral persistence in chronic hepatitis B.
    Ratnam DT; Sievert W; Visvanathan K
    Cell Immunol; 2012 Sep; 279(1):109-15. PubMed ID: 23123793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation.
    Suttmann H; Jacobsen M; Reiss K; Jocham D; Böhle A; Brandau S
    J Urol; 2004 Oct; 172(4 Pt 1):1490-5. PubMed ID: 15371877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus type 35, but not type 5, stimulates NK cell activation via plasmacytoid dendritic cells and TLR9 signaling.
    Pahl JH; Verhoeven DH; Kwappenberg KM; Vellinga J; Lankester AC; van Tol MJ; Schilham MW
    Mol Immunol; 2012 May; 51(1):91-100. PubMed ID: 22424784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inability of plasmacytoid dendritic cells to directly lyse HIV-infected autologous CD4+ T cells despite induction of tumor necrosis factor-related apoptosis-inducing ligand.
    Chehimi J; Papasavvas E; Tomescu C; Gekonge B; Abdulhaqq S; Raymond A; Hancock A; Vinekar K; Carty C; Reynolds G; Pistilli M; Mounzer K; Kostman J; Montaner LJ
    J Virol; 2010 Mar; 84(6):2762-73. PubMed ID: 20042498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape.
    Caforio M; Sorino C; Caruana I; Weber G; Camera A; Cifaldi L; De Angelis B; Del Bufalo F; Vitale A; Goffredo BM; De Vito R; Fruci D; Quintarelli C; Fanciulli M; Locatelli F; Folgiero V
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic potential of IL-15-activated cytokine-induced killer cells against human neuroblastoma cells.
    Cappel C; Huenecke S; Suemmerer A; Erben S; Rettinger E; Pfirrmann V; Heinze A; Zimmermann O; Klingebiel T; Ullrich E; Bader P; Bremm M
    Pediatr Blood Cancer; 2016 Dec; 63(12):2230-2239. PubMed ID: 27433920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs.
    Schleicher U; Liese J; Knippertz I; Kurzmann C; Hesse A; Heit A; Fischer JA; Weiss S; Kalinke U; Kunz S; Bogdan C
    J Exp Med; 2007 Apr; 204(4):893-906. PubMed ID: 17389237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions.
    Gerosa F; Gobbi A; Zorzi P; Burg S; Briere F; Carra G; Trinchieri G
    J Immunol; 2005 Jan; 174(2):727-34. PubMed ID: 15634892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth and activation of natural killer cells ex vivo from children with neuroblastoma for adoptive cell therapy.
    Liu Y; Wu HW; Sheard MA; Sposto R; Somanchi SS; Cooper LJ; Lee DA; Seeger RC
    Clin Cancer Res; 2013 Apr; 19(8):2132-43. PubMed ID: 23378384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transition to a mesenchymal state in neuroblastoma may be characterized by a high expression of GD2 and by the acquisition of immune escape from NK cells.
    Di Matteo S; Bilotta MT; Pelosi A; Haas D; Theinert T; Weber G; Schlegel PG; Berg M; Moretta L; Maggi E; Azzarone B; Vacca P; Tumino N; Caruana I
    Front Immunol; 2024; 15():1382931. PubMed ID: 38736882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
    Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
    Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing.
    Prapa M; Caldrer S; Spano C; Bestagno M; Golinelli G; Grisendi G; Petrachi T; Conte P; Horwitz EM; Campana D; Paolucci P; Dominici M
    Oncotarget; 2015 Sep; 6(28):24884-94. PubMed ID: 26298772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.